Effect of Bezafibrate or Pravastatin on Serum Lipid Levels and Albuminuria in NIDDM Patients
Open Access
- 1 January 2000
- journal article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 7 (2) , 91-96
- https://doi.org/10.5551/jat1994.7.91
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 14 references indexed in Scilit:
- Improved Insulin Sensitivity by Bezafibrate in Rats: Relationship to Fatty Acid Composition of Skeletal-Muscle TriglyceridesDiabetes, 1997
- COMPARATIVE EFFECTS OF PRAVASTATIN-INDUCED DNA SYNTHESIS ON SERUM-STIMULATED SYNCHRONIZED AND PROLIFERATIVE RAT MESANGIAL CELLSPharmacological Research, 1996
- Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gelsClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Bezafibrate Affects Lipid, Lipo- and Apolipoprotein Pattern in Non-Insulin-Dependent Diabetic PatientsHormone and Metabolic Research, 1993
- LDL stimulates mesangial fibronectin production and chemoattractant expressionKidney International, 1993
- Decreased Albuminuria by Pravastatin in Hyperlipidemic DiabeticsNephron, 1991
- Efficacy and safety of pravastatin in patients with primary hypercholesterolemiaAtherosclerosis, 1990
- Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria.BMJ, 1989
- BezafibrateDrugs, 1987